- Home
- SWX vs MDGL Comparison
SWX vs MDGL Comparison
Compare SWX & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWX
- MDGL
- Stock Information
- Founded
- SWX 1931
- MDGL 2011
- Country
- SWX United States
- MDGL United States
- Employees
- SWX N/A
- MDGL N/A
- Industry
- SWX Oil & Gas Production
- MDGL Biotechnology: Pharmaceutical Preparations
- Sector
- SWX Utilities
- MDGL Health Care
- Exchange
- SWX Nasdaq
- MDGL Nasdaq
- Market Cap
- SWX 5.6B
- MDGL 6.1B
- IPO Year
- SWX N/A
- MDGL N/A
- Fundamental
- Price
- SWX $78.60
- MDGL $432.89
- Analyst Decision
- SWX Buy
- MDGL Strong Buy
- Analyst Count
- SWX 4
- MDGL 10
- Target Price
- SWX $79.75
- MDGL $463.78
- AVG Volume (30 Days)
- SWX 345.4K
- MDGL 408.4K
- Earning Date
- SWX 11-05-2025
- MDGL 10-30-2025
- Dividend Yield
- SWX 3.16%
- MDGL N/A
- EPS Growth
- SWX 6.32
- MDGL N/A
- EPS
- SWX 2.69
- MDGL N/A
- Revenue
- SWX $4,766,188,000.00
- MDGL $515,547,000.00
- Revenue This Year
- SWX $0.03
- MDGL $394.12
- Revenue Next Year
- SWX $3.56
- MDGL $57.74
- P/E Ratio
- SWX $29.22
- MDGL N/A
- Revenue Growth
- SWX N/A
- MDGL 3421.98
- 52 Week Low
- SWX $64.69
- MDGL $200.63
- 52 Week High
- SWX $80.54
- MDGL $443.00
- Technical
- Relative Strength Index (RSI)
- SWX 52.73
- MDGL 75.83
- Support Level
- SWX $78.04
- MDGL $422.02
- Resistance Level
- SWX $79.92
- MDGL $443.00
- Average True Range (ATR)
- SWX 1.22
- MDGL 16.41
- MACD
- SWX 0.07
- MDGL 0.56
- Stochastic Oscillator
- SWX 68.35
- MDGL 88.97
About SWX Southwest Gas Holdings Inc. (DE)
Southwest Gas Holdings Inc is a utility company engaged in the purchasing, distributing, and transporting of natural gas in the American Southwest. The company segments its activities into natural gas distribution and Utility Infrastructure Services units. The first of these encompasses the company's core natural gas business as distributors in the states of Arizona and Nevada. The natural gas distribution division is responsible for roughly half of Southwest Gas' total revenue through the sale of natural gas to mainly residential and small commercial customers. The Utility Infrastructure Services segment generates the other half of the company's total revenue from the underground piping contractor services that its subsidiary, Centuri Construction Group, provides.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.